What is Known:
• General anaesthesia (GA) poses a potential risk of decompensation in children with mitochondrial disorders.
• There is a great diversity in the anaesthetic approaches undertaken in this cohort, and little guidance exists for anaesthetists and other clinicians regarding the optimal anaesthetic agents and perioperative management to provide to patients with mitochondrial disease.
What is New:
• In this study of 26 patients with genetically confirmed mitochondrial disease who underwent 65 GAs, no relationship between choice of anaesthetic agent and subsequent perioperative complication was observed
• It is likely that individual optimisation on a case-by-case basis is more important overall than choice of any one particular technique.